A recent study on psoriatic arthritis care revealed that patients and clinicians agree on key aspects of disease management ...

Psoriatic arthritis is an autoimmune condition. It happens when your body’s immune system attacks healthy tissue by mistake.

Bimekizumab (Bimzelx; UCB Pharma) was approved by the FDA to treat psoriatic arthritis (PsA) on September 23, 2024, based on ...

Most people notice symptoms of psoriasis before experiencing psoriasis-related joint pain. A common symptom of psoriasis is dry, scaly skin plaques. About 20%-30% of patients diagnosed with psoriasis ...

Arthritis can affect your fingers causing reduced mobility pain and swelling Read on to check the types of arthritis ...

Emerging evidence supports the argument that psoriatic arthritis arises from two pathways and that affected immune cells may become altered, leading to a worsening of symptoms.

The Waterloo Road actor appeared on This Morning and revealed he is turning to lifestyle changes to help manage his condition ...

LPX-TI641 is a novel, orally bioavailable, potent small-molecule immunomodulator that restores immune tolerance by targeting multiple pathways implicated in autoimmune diseases.Topline Phase 1 ...

Psoriatic arthritis (PsA) is characterised by several unique clinical features that differentiate ... Thirdly, evidence from clinical trials strongly supports a role for TNFα inhibition, as a high ...

The concordance rate for psoriatic arthritis (30%) is significantly higher than for psoriasis (7%). Twin studies in psoriasis have demonstrated a high rate of concordance among identical twins ...